Health Velocity Capital has closed its oversubscribed fund, Health Velocity Capital II, on $300m of commitments. The new fund will support early and growth-stage companies contributing to a more affordable, sustainable, and consumer-friendly healthcare system.

In the announcement of the fund, partner at Health Velocity Capital, Marty Felsenthal noted “We are extremely grateful to have the support and confidence of an outstanding group of institutional investors, strategic limited partners — and they are true partners — and senior healthcare executives who give us the opportunity to work with and for these amazing teams who are aligned with our mission of helping to build a more affordable, sustainable, consumer-friendly healthcare system. We are driven by a desire to excel for our entrepreneurs and our investors; we believe we have a highly unique model, set of relationships, and set of proof points that enable us to do this; and we never take for granted the responsibility and confidence placed in us by our investors and entrepreneurs.”

Get the week’s top news delivered directly to your inbox – Sign up for our newsletter

For more than 75 collective years, the firm’s Principals have been exclusively investing in, and building as entrepreneurs and executives, innovative healthcare software and services companies. Through their experience at Health Velocity Capital and their predecessor firms, Health Velocity Capital’s principals have worked with arms-length strategic investors for longer than almost any healthcare investment firm in the nation and partner closely with this investor base to tangibly and positively impact healthcare and the companies in whom they invest. 

Health Velocity Capital invests exclusively in innovative healthcare software and services companies. The firm’s partners have more than 75 collective years as investors, entrepreneurs, and executives helping to finance and build innovative companies that created important new healthcare markets and that became market leaders, including successful companies such as Teladoc, Livongo Health, Change Healthcare, MDLive, Contessa Health, Headspace Health, Aspire Health, Zipari, IVX Health, Well Health, Compassus, Aperio, The Advisory Board Company, Healthways (Tivity Health), US Renal Care, Spero Health, OnShift, Vantage Oncology, D2Hawkeye, Circulation Health, Payerpath, and many others.

Source: Gunder

Can’t stop reading? Read more